Yoon‐La Choi

6.5k total citations · 1 hit paper
125 papers, 3.7k citations indexed

About

Yoon‐La Choi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yoon‐La Choi has authored 125 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Oncology, 43 papers in Pulmonary and Respiratory Medicine and 39 papers in Molecular Biology. Recurrent topics in Yoon‐La Choi's work include Lung Cancer Treatments and Mutations (22 papers), Cancer Genomics and Diagnostics (20 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Yoon‐La Choi is often cited by papers focused on Lung Cancer Treatments and Mutations (22 papers), Cancer Genomics and Diagnostics (20 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Yoon‐La Choi collaborates with scholars based in South Korea, United States and Ethiopia. Yoon‐La Choi's co-authors include Young Kee Shin, Jonathan R. Pollack, Melanie Bocanegra, Jessica Kao, Mi Kwon, Pei Wang, Keyan Salari, Luc Girard, Kevin Kwei and John D. Minna and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yoon‐La Choi

119 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery

2009 611 citations Jessica Kao, Melanie Bocanegra et al. PLoS ONE profile →

Peers

Countries citing papers authored by Yoon‐La Choi

Since Specialization

Citations

This map shows the geographic impact of Yoon‐La Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoon‐La Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoon‐La Choi more than expected).

Fields of papers citing papers by Yoon‐La Choi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoon‐La Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoon‐La Choi. The network helps show where Yoon‐La Choi may publish in the future.

Co-authorship network of co-authors of Yoon‐La Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoon‐La Choi. A scholar is included among the top collaborators of Yoon‐La Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoon‐La Choi. Yoon‐La Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitor 2025 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), (unknown), Soohyun Hwang, (unknown), Boram Lee, (unknown), Hye Min Kim, (unknown), Sehhoon Park, (unknown), Jong‐Mu Sun, Jin Seok Ahn, (unknown), Yoon‐La Choi, Chang Ho Ahn, (unknown), Chan‐Young Ock, Se-Hoon Lee	1
2	Indirect targeting of MYC and direct targeting in combination with chemotherapies are more effective than direct mono-targeting in triple negative breast cancer 2024 ·Translational Oncology ·(unknown), Hobin Yang, Nirmal Rajasekaran, Kyoung‐Ho Song, Yoon‐La Choi, Young Kee Shin	2
3	c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer 2024 ·Breast Cancer Research ·Jieun Park, (unknown), Ji‐Yeon Kim, Chaithanya Chelakkot, (unknown), Jiyoung Song, Kyungsoo Jung, (unknown), Jun Yong Choi, (unknown), (unknown), (unknown), Mi Kwon, Young Kee Shin, Winnie Yeo, Yoon‐La Choi	12
4	Real-time assessment of relative mitochondrial ATP synthesis response against inhibiting and stimulating substrates (MitoRAISE) 2024 ·SHILAP Revista de lepidopterología ·(unknown), Kyoung Song, Jie Song, (unknown), Mi‐Sook Lee, (unknown), Ji‐Yeon Kim, Yeon Hee Park, Kyungsoo Jung, Yoon‐La Choi	0
5	Trends and Clinical Characteristics of Next-Generation Sequencing–Based Genetic Panel Tests: An Analysis of Korean Nationwide Claims Data 2023 ·Cancer Research and Treatment ·Mi Jang, (unknown), (unknown), Hyunsun Lim, Yoon‐La Choi, Hyo Sup Shim, Eun‐Kyung Kim	1
6	Korean Precision Medicine Networking Group study of molecular profiling guided therapy based on genomic alterations in advanced solid tumors (KOSMOS) II (KCSG AL 22-09). 2023 ·Journal of Clinical Oncology ·Sun‐Young Kim, Jee Hyun Kim, Tae Yong Kim, Sook Ryun Park, Shinkyo Yoon, Soo Hyun Lee, Se‐Hoon Lee, Tae‐Min Kim, Sae‐Won Han, Hongseok Yun, Sejoon Lee, Jihun Kim, Yoon‐La Choi, Kui Son Choi, Heejung Chae, Hyewon Ryu, Gyeong‐Won Lee, Dae Young Zang, Joong Bae Ahn	0
7	Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity 2020 ·Journal for ImmunoTherapy of Cancer ·Tae Hee Hong, Hongui Cha, Joonho Shim, Boram Lee, Jongsuk Chung, Chung Lee, Nayoung K. D. Kim, Yoon‐La Choi, Soohyun Hwang, (unknown), Sehhoon Park, Hyun Ae Jung, Ji‐Yeon Kim, (unknown), Jong‐Mu Sun, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park, Se‐Hoon Lee, Woong‐Yang Park	10
8	Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting 2019 ·Biomolecules ·Hobin Yang, (unknown), Yong Jin Lee, (unknown), Taeeun Kim, Nirmal Rajasekaran, (unknown), Kyoung Song, Sungyoul Hong, Joon-Seok Choi, Hyunbo Shim, (unknown), Soohyun Hwang, Yoon‐La Choi, Young Kee Shin	9
9	Identification of tumor suppressor miRNAs by integrative miRNA and mRNA sequencing of matched tumor–normal samples in lung adenocarcinoma 2019 ·Molecular Oncology ·Namhee Yu, (unknown), Hong Kwan Kim, Yoon‐La Choi, Yeonjoo Jung, Doyeon Kim, Jihae Seo, (unknown), Daehyun Baek, Jinseon Lee, Seungjae Lee, Jong Eun Lee, Jaesang Kim, Young Tae Kim, Sang‐Hyuk Lee	42
10	Unforeseen clonal evolution of tumor cell population in recurrent and metastatic dermatofibrosarcoma protuberans 2017 ·PLoS ONE ·Ensel Oh, Hae Min Jeong, Mi Kwon, Sang Yun Ha, Hyung Kyu Park, Ji‐Young Song, Yu Jin Kim, Jong‐Sun Choi, Eun Hee Lee, Jeeyun Lee, Yoon‐La Choi, Young Kee Shin	8
11	A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2− early breast cancer 2017 ·Scientific Reports ·Gyungyub Gong, Mi Kwon, Jinil Han, Hee Jin Lee, Sang Kook Lee, Jeong Eon Lee, Seon Heui Lee, Sarah Park, Jong‐Sun Choi, Soo Youn Cho, Sei Hyun Ahn, Jong Won Lee, (unknown), (unknown), Byung‐Ho Nam, Seok Jin Nam, Yoon‐La Choi, Young Kee Shin	25
12	Girdin protein expression is associated with poor prognosis in patients with invasive breast cancer 2017 ·Pathology ·Jong‐Sun Choi, Kyung‐Hee Kim, Ensel Oh, Young Kee Shin, Jinwon Seo, Seok‐Hyung Kim, Sarah Park, Yoon‐La Choi	12
13	Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo 2015 ·International Journal of Molecular Sciences ·Hun Jung, Nirmal Rajasekaran, (unknown), Young Ho Kim, Sungyoul Hong, Hyuck Jae Choi, Dae Young Kim, Jong‐Sun Choi, Yoon‐La Choi, Young Kee Shin	22
14	Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach 2015 ·Medicine ·Hyun Jung Yoon, Insuk Sohn, Jong Ho Cho, Ho Yun Lee, Jae‐Hun Kim, Yoon‐La Choi, Hye Seung Kim, Genehee Lee, Kyung Soo Lee, Young Tae Kim	101
15	Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue Samples 2015 ·PLoS ONE ·Ensel Oh, Yoon‐La Choi, Mi Kwon, Ryong Nam Kim, Yu Jin Kim, Jiyoung Song, (unknown), Young Kee Shin	71
16	Patient-Derived Xenografts from Non–Small Cell Lung Cancer Brain Metastases Are Valuable Translational Platforms for the Development of Personalized Targeted Therapy 2014 ·Clinical Cancer Research ·Hye Won Lee, Jung-Il Lee, Se Jeong Lee, Hyun Jung Cho, Hye Jin Song, Da Eun Jeong, Yun Jee Seo, Sang Hyun Shin, Je‐Gun Joung, Yong‐Jun Kwon, Yoon‐La Choi, Woong‐Yang Park, Hyun Moo Lee, Ho Jun Seol, Young Mog Shim, Kyeung Min Joo, Do‐Hyun Nam	47
17	SMAD4 Suppresses AURKA-Induced Metastatic Phenotypes via Degradation of AURKA in a TGFβ-Independent Manner 2014 ·Molecular Cancer Research ·(unknown), (unknown), Chun Fu Wu, Juthika Kundu, Sang Gyu Park, Ryong Nam Kim, Lihui Wang, Özgür Cem Erkin, Jong‐Sun Choi, Seoung Wan Chae, (unknown), Yoon‐La Choi, Young Kee Shin	17
18	LYN Is a Mediator of Epithelial-Mesenchymal Transition and a Target of Dasatinib in Breast Cancer 2010 ·Cancer Research ·Yoon‐La Choi, Melanie Bocanegra, Mi Kwon, Young Kee Shin, Seok Jin Nam, Jung‐Hyun Yang, Jessica Kao, Andrew K. Godwin, Jonathan R. Pollack	126
19	Expression of MET in alveolar soft part sarcoma 2009 ·Medical Oncology ·Hyun Jung Jun, Jeeyun Lee, Do Hyoung Lim, Joon Oh Park, Geunghwan Ahn, Sung Wook Seo, Ki-Sun Sung, (unknown), Keon Hee Yoo, Yoon‐La Choi	19
20	Centrosomal PKCβII and Pericentrin Are Critical for Human Prostate Cancer Growth and Angiogenesis 2008 ·Cancer Research ·Jeewon Kim, Yoon‐La Choi, Alice Vallentin, (unknown), Marc K. Hellerstein, Donna M. Peehl, Daria Mochly‐Rosen	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact